Lynch Karen S
- SEC CIK
- 0001333760
No open-market purchases or sales filed in the past year.
Current role at each company
- TMO Thermo Fisher Scientific Inc.Directoras of Jun 30, 2026
- ADP Automatic Data Processing IncDirectoras of Nov 14, 2025
- CVS CVS Health CorpPresident and CEOas of Apr 3, 2024
- USB US Bancorp DEDirectoras of Dec 20, 2021
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Lynch Karen S as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
CVS CVS Health Corp
President and CEO1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| May 5, 2023 (view filing) | May 3 | 2 days | Lynch Karen SPresident and CEO | PPurchaseCommon Stock (By Trust) | +14.0K | $69.75 | +$976.5K | +3.4%431.4K after |